���������� ������������� ������

����������� ������������

�� ����������� � ������� ��������� ��������� �����,

�������������� ������������ � ������������ ������

Клинические рекомендации обсуждены и утверждены на Пленуме Правления Ассоциации нейрохирургов России г. Санкт-Петербург, 16.04.2015 г

�����, 2015

  

      

2+ class="tr0 td1">

    ,  ,

 

  

    

 

 

    

 

2+ class="tr1 td5">

      !" #

 

2+ class="tr2 td7">

 

$$     %  

2+ class="tr3 td5">

&      ,  

 

2+ class="tr0 td5">

  '    

 

 

  

 

2+ class="tr0 td5">

      !" #

 

2+ class="tr2 td7">

 

(   ) )  

2+ class="tr0 td5">

    ,  

 

2+ class="tr0 td5">

  '    

 

 

  

 

2+ class="tr0 td5">

      !" #

 

2+ class="tr2 td7">

 

&  Алексей Витальевич

2+ class="tr4 td5">

&      ,  

 

2+ class="tr5 td5">

  '    

 

 

  

 

2+ class="tr0 td5">

      !" #

 

2+ class="tr2 td7">

 

   *   

2+ class="tr0 td5">

    ,

 

  

 

 

2+ class="tr0 td5">

  **  

 

2+ class="tr1 td5">

.  . ..+ 

 

 

 

�!"#$#%#&'# !�&()'*

�) &$ ")

  ' '      , '                  (,   $       '    ,   -      '       ).

�#��+#&$ ,'(

-  '        ,    '      . ,    '  . !         ' '     '   

2

   (,   $   '   '       '       ).

�!,'(

-  '         , '  '  ' (,   $      ' , ,   '      ).

�# "#��+#&$-#)�(

-  '        ,     $  ,         (     $  ).

 

 

2+ class="tr0 td2">

�./'# ��#$#&'(

 

 

 

 

6+ class="tr1 td7">

     ()!) ,  

2+ class="tr1 td8">

 

3+ class="tr1 td9">

   ,     

  



2+ class="tr1 td11">

  

 ,

3+ class="tr2 td9">

$     

   .

4+ class="tr2 td12">

/   )!   

2+ class="tr1 td13">

  '   

2+ class="tr1 td2">

   

4+ class="tr1 td12">

        8%,

6+ class="tr1 td7">

  '    1-2%. / %( $    

2+ class="tr1 td8">

  2500

5+ class="tr1 td14">

 '  )!. %     ' 40-50

2+ class="tr1 td11">

. /  

)!

2+ class="tr1 td13">

   $ [2,34,44].

 

 

 

 

 

 

%  

 '

3+ class="tr1 td16">

     

3+ class="tr1 td17">

8-25%. &   

$  

7+ class="tr2 td18">

    '    :   

(&)   $  '     [1,4,10].

)�0# ���

          '         [1,2,4,7,62]:

1.& ' (  ,  '  ,     ' ',       )

2.)   ' [4,16,22,23,34, 64-66]

  

0 

3

+, '

1 

) ' $'  

  

*     

/.'  

+   ' , 

/$ '    (   # ,   ' )

3.0   

4.2 ' (    .  )

5.& '

�)'�%�0'( ���

0   )! $  '   '   

   $                   .

%   , ''  )!,   .,      ,

'    '. %   '     

3  (Toxoplasma gondii),         

 /*4   [22,23].

1.+  

%  ( ,' ,  ,' ,  , ' )

" '   

) -  '    (Proteus spp., Escherichia coli, Klebsiella spp, P.aeruginosa, Enterobacter spp.)

 ,' (Bacteroide spp., Prevotella spp.)

!$  '    '  '      14- 28%  '. 4    '     . . 0  '  ' $    43%        [22,40,50].

4

     '   : Listeria spp., Salmonella spp.,

Noardia spp., H. influenza, Streptococcus pneumonia, Actinomyces,

Mycobacterium tuberculosis, Citrobacter diversus [8,15,20,52,53,71].

2.)'

"   '   ' )!  . 1             ,       .   . & ' '      [2,20,64,69]:

Candida spp.

Aspergillus spp.

������ Mucorales

Rhizopus arrhizus

Scedosporium

Cryptococcus neoformans

Coccidioides spp

Histoplasma spp

Blastomyes dermatitidis

3   1. * '       

    [64]

2�&���# 1 .�%#� &'#

2+ class="tr3 td20">

�&3#�,'�&&4* 0#&)

 

 

%  / 

4+ class="tr4 td24">

Streptococcus spp., Bacteroides spp., Prevotella spp.,

 

Enterobacteriaceae

 

 

 

 

 

 

 

 

%

Streptococcus

spp.,

Bacteroides

spp.,

(, ' ,

3+ class="tr7 td34">

Enterobacteriaceae, S.aureus, H. influenzae

 

  ' )

 

 

 

 

 

4+ class="tr8 td35">

 

   

4+ class="tr6 td24">

Fusobacterium spp., Bacteroides spp., Prevotella spp.,

 

3+ class="tr7 td36">

Actinomyces, Streptococcus spp.

 

0 

2+ class="tr4 td37">

S.aureus, Streptococcus

2+ class="tr4 td38">

spp., Enterobacteriaceae,

5

4!3/  

Clostridium spp.

 

 

  , ,  ,

Fusobacterium spp., Bacteroides spp., Prevotella spp.,

, '

Actinomyces, Streptococcus spp, Nocardia spp

+   ' , 

S.aureus, Streptococcus spp.

/$ '   

Streptococcus spp., H. influenzae

2+ class="tr5 td16">

�++-&�$#3',')&4# ���)�(&'(

  

Enterobacteriaceae

 

Candida spp.

 

Aspergillus spp.

3   

Enterobacteriaceae

 

L. monocytogenes

 

Nocardia spp.

 

Candida spp.

 

Aspergillus spp.

 

T. gondii

 

 

/*4- 

T. gondii, Nocardia spp., Mycobacterium spp.,

 

Cryptococcus spp.

 

 

�% ��'3'� ,'( �) $'* " 1�')'( ��� [9,67]

I.     (1-3 )

0         ,       ,  ,         

)       .        . 5'     .       3 

II.0    (4-9 )

6        . ) '     

  '        . 6       .       . 6   '      .

III.%         ' (10-13 )

6 .  '      . 6                 . !          . 1         '. 6 .  '      . 6    .

6

IV. %        ' (14    )

 .  .       .  .

       . &    

    2   .

6 .      .

     . )     

    3   .

. . &    .         )!   $      [7]:

3   2. &       )!

0   

2+ class="tr4 td42">

- 

 

3  



 

/



 

2+ class="tr4 td46">

" '  

 

2+ class="tr7 td48">

!$ 

0 

2+ class="tr4 td46">

%     

 

2+ class="tr4 td46">

2     

 

 

 

0     

 

 

 

2+ class="tr4 td46">

  ( 3    4!3)

 

2+ class="tr7 td46">

0 ( 3    4!3)

 

 

 

0    

% 

 

 

% 

 

 

2+ class="tr9 td46">



 

2+ class="tr12 td48">

 

0   

2+ class="tr6 td46">

'

 

2+ class="tr9 td46">

!$  '

 

2+ class="tr5 td48">

 

0 &3       $

2+ class="tr9 td48">

) '

7

 

)  '

 

)   '

 

* '

 

 

0 .         

1 '



% '

 

/' .

 

0   '

0 

  '

 

  '

 

!  '

0 7 

! ' ,  20 

 

%  , 21—40 

 


+ . , 41—60 

 

)  ,  60 

0     

&  

 

%  

 

6      

 

)    

 

3     .

 

 

0 !3     

 $ 31  ' 

 

      '

 

  

 

 $ 32 -  ' 

 

      '

 

  

0   

1   

 

&  

 

 

0     

'

 

0'

 

9 

�#��+#&$ ,''. /          .      '    )!,                    . 0     )!        

&  . .     (2004) �!,'(

0  .                 .  ' )   .   ' ) .

�%'&'5#�� ( �'+!)�+ )'�

&     $          

         . /  ' ,      .   '.    

8

   . 0     '          $       '   $  . 6 . 

   1   $   $        

'  10 %.

&     )!      ,                    50 %.

&           )!   '

  (  . 3). /  ' )!    '     3. [2,4,16,21,34,39,42,68]

2+ class="tr9 td51">

3   3. &  

3+ class="tr9 td52">

   )! [22,64]

2+ class="tr13 td51">

 

 

 

 

2+ class="tr4 td56">

�'+!)�+4/�'&$"�+4

 

� �)�) %

 

2+ class="tr14 td59">

 

 

 

 

2+ class="tr4 td51">

)   

 

49-97

 

 

 

 

 

 

- 

 

 

32-79

 

 

 

 

 

 

# '

   

 

23-66

 

 

 

 

 

 

 . 



 

28-91

 

 

 

 

 

 

0 

 

 

13-35

 

2+ class="tr15 td70">

 

 

 

 

2+ class="tr6 td71">

3. /

 

27-85

 

2+ class="tr15 td70">

 

 

 

 

2+ class="tr4 td71">

!  ' 

 

5-41

 

3+ class="tr14 td72">

 

 

 

3+ class="tr4 td73">

    '  

9-51

 

2+ class="tr16 td70">

 

 

 

 

2+ class="tr6 td71">

)    ' 

 

11-25

 

 

 

 

 

 

2+ class="tr9 td74">

3   4. &  

3+ class="tr9 td75">

         [2,4,64]

2+ class="tr13 td76">

 

 

2+ class="tr13 td78">

 

2+ class="tr4 td79">

��� %'1 ,'(

 

2+ class="tr4 td81">

�%'&'5#�� ( �'+!)�+ )'�

2+ class="tr15 td82">

 

 

 

 

2+ class="tr6 td79">

-  

 

)   

 

 

 

 

 

 

 

 

 

2+ class="tr4 td81">

 .   

 

 

 

  -  

 

 

 

 

2+ class="tr4 td81">

0, '   

 

 

 

)   

 

 

 

 

  '  



/

 

 

*   

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 .  

  /)  

3  



 

)   

 

 

 

 

 .  

  /  

 

 

 

 . 

 

9

 

 / 

" '  

)   

 

3. / 

 

)  

!$ 

)   

 

 

 

 

 

3. /

 

 

 

! 

 

    '  

%   

0  '   -'  

 

   '

�' 0&��)'� ���

������������ ����������� (��������)

/    ,  '      )!  $' '   '       .      '   ,         . /      '             . 6 60-70%

'   ,  90%   %1. 6  %1    %-                              7 '   '   .

%       (�) &$ "))               . &        2  . %                  ,          '  .

- '  (�!,'() -       '  )!   $     -  ' . *    :%;    ' '. &    '     $  ,          61-

10

81%,       60-70%. +         )!      (�!,'().

/'         )!    ,  &# "#��+#&$-#)�( [2,4].

����������������� (��������)

&             '

  '  )!  95-99%  ',    &3         $     )!       .             ,             . 3              '  $', $   $   . )     )! '                  . &3      $    )!  :

  

&  

   -, 

      ' 

  $  '

/   $ ' )!   ,  

&3               -            .

! -          . !3 '        )!. !3             ,    $      '

11

 . 0 31- $     )!   

 '       '  . 0

               ,

$    '          . / 32-

 $           '  

 ,       '  . /    

                 [5,6,26-

29,37,50,54,70]

�) &$ ")

)      )!      '         ,    &3  !3.   $   )!       &3   '

   . �#��+#&$ ,'(

!3         '                ,                  , '       ,   )!

3+ class="tr9 td31">

�'33#"#&,' %6& ( $' 0&��)'�

 

 

 

3+ class="tr10 td31">

   ' <  )!



2+ class="tr10 td35">

  ' 

'

 

 

 ,

.  

 

       ,  .

%          ' '          $    .      '              . 0              ,              ,    '  '               .             , $    ,

12

,      . "    $       '    . 0 &3     .  )!         '  '      ,  ,             .          !3   

                 . !             '   [58].

2�"+-%'"��� $' 0&�1 ' ���) �%#&'# !% & %#5#.&47 +#"�!"'()'*.

/     $' '   ' (�) &$ ")):

I. 6           )!;

II.6   ,  )!;

%  

   '    ,  

  ,

  

       

, 

 ,        $'    .

          '   

 

       '  ' (    ):

 

      '         7 

,    

    

   

    

    

�#5#&'# ���

������������������

13

-   )!         .    ,  $ .         )!. 0                      .  '                  . 0       ,     .              ' 3   . 5  $'      S.aureus             7 '  '   . 6   , ' ,     )!      '   ',      P. aeruginosa   '     ,         . 0   -         )!        ,       ' 3-4   . 0             [1,2,4,11,22,31-33,41,43,64].

2+ class="tr0 td32">

3   5.

1 

2+ class="tr0 td40">

      ' )!    

3+ class="tr12 td41">

,     .

 

 

3+ class="tr13 td41">

 

 

 

3+ class="tr5 td44">

2�&���# 1 .�%#� &'#

�&3#�,'�&&4* 0#&)

 

% 

2+ class="tr5 td47">

/ 

!   +   ' 3  

 

 

 

 

 

 

%

 

 

!   +   ' 3   +

 

3+ class="tr5 td14">

(, ' ,

 

 

3+ class="tr6 td14">

  ' )

 

 

2+ class="tr16 td53">

 

 

 

 

2+ class="tr5 td53">

 

 

0   +   

 

2+ class="tr5 td54">

0 

 

/  +   ' 3   4  

 

3+ class="tr5 td14">

4!3/  

 

 

 

2+ class="tr2 td55">

 

 

 

 

2+ class="tr5 td55">

, ,  ,

0   +    +    '

 

14

, '

 

+   ' , 

/  +   

/$ '   

:  ' 3  

  

!   +   ' 3   4

 

  +  

3   6.         

� )�0#&

�) &$ ")& ( )#" !'(

�%6)#"& )'�& ( )#" !'(

 

 

 

� �)#"'(

 

 

 

 

 

Streptococcus spp.,

   G

:  ' 3  

 

 

(  /  ),

 

 

 

 

 

 

Bacteroides spp.,

!  

&  

 

 

 

Prevotella spp.,

!  

&  ,   

 

 

 

Enterobacteriaceae

:   3   4

   ,  '

 

 

 

 

 

 

S. aureus

  

/ 

MSSA

 

 

 

 

 

S. aureus

/ 

/ 

MRSA

 

 

 

 

 

Haemophilus spp

:  ' 3  

 '

 

 

 

Fusobacterium spp.

0   G

!  

 

 

 

Actinomyces spp.

0  

&  

 

 

 

ycobacterium spp.

2+ class="tr20 td107">

* + +0  +, 

 

 

 

Nocardia spp.

&- 

   ,  ,

 

 

  ' 3  

 

 

 

Pseudomonas aeruginosa

:  ,   

:    

 

 

   

 

 

 

�"'.4

 

 

 

 

 

Candida spp.

#  

  /

 

 

 

Aspergillus spp.

/ 

  /,   

 

 

 

������ Mucorales

0  

  /

 

 

 

Scedosporium

/ 

  

 

 

 

Cryptococcus spp.

#  

  /

 

 

 

15

/$         

/$         

0                    ' in vitro  . 6       $          [1,2,22,53,64,71].

3   7.    ' '   )!   ' 

  

2+ class="tr0 td56">

      [1,2,22,64]

 

 

 



 

%  (/)

 

 

 

 

 

15 /

 

 

 

  /

 

0,5-1 /

 

 

 

 

 

12 

 

 

 

/ 

 

30-45 /

 

 

 

/ 

 

8 /

 

 

 

)  

 

5 /

 

 

 

* 

 

300 

 

 

 

!   

 

6 

 

 

 

  

 

9-12 

 

 

 

0  

 

24   5

 

 

 

0  

 

800 

 

 

 

0  

 

15-30 /

 

 

 

 

 

600

 

 

 

 

5 /

3 

 

 

 

 

 

-  

 

10-20 /

 

 

 

:  

 

6 

 

 

 

:  

 

8-12 

 

 

 

:  

 

6 

 

 

 

:  

 

4

 

 

 

:  

 

800-1200 

 

 

 

16

#  

800



 

 

 

# 

200

/

 

 

 

-           

��������������� �������� ��������������� �������

&    

1              )!        .  . - '     '.  /4  $      '     . 6      , ' $ '  -,   $       $  ' ,  '    10   $' 6                    . %  '  '    $  /4 ,        '  .           '  .            [11,16,21,40].

�!,'(

&       $  /4                   )!.             .

  '

            )!   '   . 3    $     6         ,     '  ' 11).

�'"-"0'5#���# %#5#&'#

17

:     

 .   -, 

       

             

    %   2 '      )![2,17,22,64]:

1.'      

2.   (freehand -  ,      ,

,  ,      6"-    )

/'    )!      :

  

7 

      '

   

    

' 

2+ class="tr0 td64">

"  

3+ class="tr0 td65">

 '     $ ,

   

 

 .

 

 

 

 

4+ class="tr22 td72">

����������� ���������

 

 

2+ class="tr12 td64">

 

 

 

2+ class="tr12 td73">

'   .   ,  $

2+ class="tr12 td64">

  

4+ class="tr12 td74">

    . 1     

$ 

2+ class="tr22 td75">

'  

.

5 '

    

   $  '        [19,24,25,27,28,35,55].

0                      )!:

  3    1,5 

   $  0   ,   :

18

   

$        '  

$   )!  '  $  

�������� ���

6       [2,4,22,56,57,64]:

$ ' )!

)!         $ '  

0    )! (      $  '    , '  )

)  $  )!

!   ' )! (      ) [38]

 ,  '  

�#��+#&$ ,'(

%       )!     '   .  '. 6  )!        :

$ ' )!

)!         $ '  

0    )! (      $  '    , '  )

)  $  )!

!   ' )!

 ,  '  

3    )!   .                .     '      '           .

!      '         :

1. /'      $ '  '    

19

2.!$  '   

3.)!      $      7 

4.%     /  

5.   $              '    

6.)! 2,5                ,       .   $  $    ' 

         6-8    '                    '      2-3    . 0   , ' '     )!     ,    $     3-4   . 3        '       $ '     (  12         '     ).

�)'� %#5#&'( �)$#%6&47 0"-!! .�%6&47

��������� ���

)' )!      $    '  '   . -    ,   '            '  . 3        ' )! ,             . &    /             ,         ' )! [2,4,22,64].

��� �� ���� ���������������� ���������

*  ,          )!. %$  3-           '   ,     Aspergillus spp, Nocardia spp.   '      ',  '  '  $  , /*4,

20

        ,       $    ' $      .              $                         [12,14,18,36,59,61,63,73].

/63*4550=5 10* 6->=5 * %6+ 6->=5 1!0*5!= %  ,  - ,        $            . %  ,     15-20%     '   . /    ' ,  , ', ' '    40-80%    ' ,  . !         , '         10-20%    [45-49]. & 

          [3,22]:

4!3

0    '     .  

* '  $        '

�������������� ������

%  (25-45%)

%   (10-15%)

,'    '    (3-10%)

 ,'      ,' (33-100%)

  '   7-53%

0    ' ,   '          '    [44].

1  ,  ,       $            . 1 ' , '      2%      '   .

21

0         ,      '  ' ,  .

!���������� �������

&          '.  /4 . 9        ,   '    '           . 0           ' ' .      . 0       30-80%  '. /  $    '   ' ,  ,        .             ',           .

& ' $            , . ,  ,   '  . /  ,      $       '      . 0                         .  ,  -, ,  [2,4,22,64].

"����������

       '             . &     '     '   '    . - '          ,    .

&                          . &3             '       $ '  '. 0 &3 '          ,-    . !3         '    , ,      $ .              . 6        .   ,              

22

/  . 1  ' '      31  32  $  [72].

�������

/   ,  , ,        . 0,     $        '     . :      ,        ,   , '.

 '         $  . /' 7    $        ',       (&),    -,       ' , ,    .

" '  $    , ' ,  ' . &    ,     $               , ,   , '         '     . &     ,                  ,  $             - ,  ,        '     .    ,  $  $       '     . 0,  '     .               .     ,      $ .   .

0      ,   .          , '. /            $  '       .

3        ' ,          '  )!. /                $ '    3-4        . 6  '           6-8    (       '  ).

23

          $      

  :      ,   '  '   ,   '   ,  -,       '

   '    ,    $    .

3     ,   '          

        , '  ' &3/!3.

-    '  , ' ,    $                    

  .

&  /,

     



  

    

        . 3  

 

        3-6   . 0   ,  , '    '  .       $  '  .'  50%     [1-7,30,51,60,62].

   

&  / ,         ,  ,                '   .     $        ' . /      ,    , (&), ,     ,  '    .

24

-  

1.   /.)., (  /.., (   +.. %           //     $ .— 2000.— 3. 8. — No 13–14.

2.)$  ./., +  ./. / .:   : . 3 2. - ,   ',     '. 0  . ..   . -!., 2013, - 735-843.

3.    .. 0      ,   .: &  

    -     . .. &  , -.+. -   , .. 0  // ! ., . – 2002 - . 407-411

4.-    /./., &'  /./.   $   .     . – !.:

!  . – 2000. – . 339-365.

5.&  .., &  /.. &          . — !., 1985.

6.&  .., &  /.., 0 *.. ! -       . — !., 1997.

7.&  . ., 0  .., -   -.+., -  /.).  '  

 //&      . - !.: !  . - 2004. – 3.3. – .2. - %. 290-300.

8.Bayindir C, Mete O, Bilgic B: Retrospective study of 23 pathologically proven cases of central nervous system tuberculomas. Clin Neurol Neurosurg 108:353–357, 2006.

9.Britt RH, Enzmann DR, Yeager AS. Neuropathological and computerized tomographic

25

findings in experimental brain abscess. J Neurosurg. 1981;55:590-603.

10.Calfee D.P., Wispelway B., Brain abscess. Seminar Neurology 2000. – 20. – p. 353- 360

11.Cavusoglu H, Kaya RA, Turkmenoglu ON, et al. Brain abscess: analysis of results in a series of 51 patients with combined surgical and medical approach during an 11-year period. Neurosurgical Focus. – 2008. – 24(6). – E9

12.Collazos J: Opportunistic infections of the CNS in patients with AIDS: Diagnosis and management. CNS Drugs 17:869–887, 2003.

13.d’Arminio Monforte A, Cinque P, Vago L, Rocca A, Castagna A, Gervasoni C, Terreni MR, Novati R, Gori A, Lazzarin A, Moroni M: A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients. J Neurol 244:35–39, 1997.

14.Del Brutto OH, Roos KL, Coffey CS, García HH: Meta-analysis: Cysticidal drugs for neurocysticercosis: Albendazole and praziquantel. Ann Intern Med 145:43–51, 2006.

15.Eckburg PB, Montoya JG, Vosti KL: Brain abscess due to Listeria monocytogenes: five cases and a review of the literature. Medicine (Baltimore). 2001 80:223-235

16.Erdogan E, Cansever T: Pyogenic brain abscess. Neurosurg Focus. 2008 24 (6):E2

17.Guyot LL, Duffy CB, Guthikonda M, Natarajan SK. Epidural abscess, subdural empyema, and brain abscess. In: Atlas of neurosurgical techniques. LN Sekhar, Fessler RG. // 2006.- p.975-982

18.Garcia HH, Del Brutto OH; Cysticerosis Working Group in Peru: Neuro- cysticercosis: Updated concepts about an old disease. Lancet Neurol 4:653– 661, 2005.

19.Gildenberg PL, Gathe JC, Kim JH: Stereotactic biopsy of cerebral lesions in AIDS. Clin Infect Dis 30:491–499, 2000.

20.Hagensee ME, Bauwens JE, Kjos B, et al.: Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Center, 1984-1992. Clin Infect Dis. 19:402-408 1994

21.Hakan T: Management of bacterial brain abscesses. Neurosurg Focus. 2008 24 (6):E4

22.Hall WA, Truwit CL. The surgical management of infections involving the cerebrum. In Surgery of the human cerebrum M. Apuzzo. 2009.- p. 519-531

23.Hall WA: Cerebral infectious processes, in Loftus CM (ed): Neurosurgical Emergencies. Park Ridge, American Association of Neurological Surgeons Publications, 1994, vol 1, pp 165–

24.Hall WA: The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer 82:1749–1755, 1998.

25.Hall WA, Liu H, Martin AJ, Maxwell RE, Truwit CL: Brain biopsy sampling by using prospective stereotaxis and a trajectory guide. J Neurosurg 94:67–71, 2001.

26.Hall WA, Liu H, Martin AJ, Pozza CH, Maxwell RE, Truwit CL: Safety, efficacy and

functionality of high-field strength interventional MR imaging for neurosurgery. Neurosurgery 46:632–642, 2000.

27.Hall WA, Truwit CL: Intraoperative MR imaging. Magn Reson Imaging Clin N Am 13:533–543, 2005.

28.Hall WA, Truwit CL: 1.5 T: Spectroscopy-supported brain biopsy. Neurosurg Clin N Am 16:165–172, vii, 2005.

29.Hall WA, Truwit CL: 3-tesla functional magnetic resonance imaging-guided tumor resection. Int J CARS 1:223–230, 2006.

30.Heran NS, Steinbok P, Cochrane DD: Conservative neurosurgical management of intracranial epidural abscesses in children. Neurosurgery 53:893–898, 2003.

31.Husain M, Jha DK, Rastogi M, Husain N, Gupta RK: Neuroendoscopic management of intraventricular neurocysticercosis. Acta Neurochir (Wien) 149:341–346, 2007.

32.Husain M, Rastogi M, Jha DK, Husain N, Gupta RK: Endoscopic transaqueductal removal of fourth ventricular neurocysticercosis with an angiographic catheter. Neurosurgery 60

26

[Suppl]:249–254, 2007.

33.Jansson AK, Enbland P, Sjolin J: Efficacy and safety of cefotaxime in combination with metronidazole for empirical treatment of brain abscess in clinical practice: a retrospective study of 66 consecutive cases. Eur J Clin Microbiol Infect Dis. 2004.-23.-p.7-14

34.Kastenbauer S, Pfister HW, Wispelwey B, et al.: Brain abscess. Scheld WM Whitley RJ Marra CM Infections of the Central Nervous System. 3rd ed 2004 Lippincott Williams & Wilkins Philadelphia 479-507

35.Kocherry XG, Hegde T, Sastry KVR, et al.: Efficacy of stereotactic aspiration in deep- seated and eloquent-region intracranial pyogenic abscesses. Neurosurg Focus. 2008.-24 (6).- p.E13

36.Kennedy PGE: Viral encephalitis. J Neurol 252:268–272, 2005.

37.Leuthardt EC, Wippold FJ, Oswood MC, Rich KM: Diffusion-weighted MR imaging in the preoperative assessment of brain abscesses. Surg Neurol 58:395–402, 2002.

38.Lee GYF, Daniel RT, Brophy BP, et al.: Surgical treatment of nocardial brain abscesses. Neurosurgery. 2002 .- 51.-p.668-672

39.Lee TH, Chang WN, Thung-Ming S, et al.: Clinical features and predictive factors of intraventricular rupture in patients who have bacterial brain abscess. J Neurol Neurosurg Psychiatry. 2007.- 78.-p.303-309

40.Lu CH, Chang WN, Lin YC, et al.: Bacterial brain abscess: microbiological features, epidemiological trends and therapeutic outcomes. Q J Med. 2002.-95.-p.501-509

41.Mamelak A.N., Mampalam T.J., Obana W.G., Rosenblum M.L. Improved management of multiple brain abscesses: a combined surgical and medical approach // Neurosurgery. — 1995 Jan. — Vol. 36 (1). — . 76–85.

42.Mathisen G.E., Johnson J.P. Brain abscess // Clin. Infect. Dis. — 1997 Oct. — Vol. 25 (4).

. 763–779.

43.Mampalam TJ, Rosenblum ML: Trends in the management of bacterial brain abscesses: a review of 102 cases over 17 years. Neurosurgery. 23:451-458 1988

44.McClelland S III, Hall WA: Postoperative central nervous system infection: incidence and associated factors in 2111 neurosurgical procedures. Clin Infect Dis. 45:55-59 2007

45.Nathoo N, Nadvi SS, Gouws E, et al.: Craniotomy improves outcomes for cranial subdural empyemas: computed tomography–era experience with 699 patients. Neurosurgery. 49:872-878 2001

46.Nathoo N, Nadvi SS, van Dellen JR, et al.: Intracranial subdural empyemas in the era of computed tomography: a review of 699 cases. Neurosurgery. 44:529-535 1999

47.Nathoo N, Nadvi SS, van Dellen JR: Infratentorial empyema: Analysis of 22 cases. Neurosurgery 41:1263–1268, 1997.

48.Nathoo N, Nadvi SS, van Dellen JR: Cranial extradural empyema in the era of computed tomography: A review of 82 cases. Neurosurgery 44:748–753, 1999.

49.Nimsky C, Ganslandt O, Hastreiter P, Fahlbusch R: Intraoperative compensation for brain shift. Surg Neurol 56:357–365, 2001.

50.Osenbach RK, Loftus CM: Diagnosis and management of brain abscess. Neurosurg Clin N Am 3:403–420, 1992.

51.Osborn MK, Steinberg JP: Subdural empyema and other suppurative complications of paranasal sinusitis. Lancet Infect Dis. 7:62-67 2007

52.Peleg AY, Husain S, Qureshi ZA: Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. Clin Infect Dis. 44:1307-1314 2007

53.Poonnoose SI, Rajshekhar V: Rate of resolution of histologically verified intracranial tuberculomas. Neurosurgery 53:873–879, 2003.

54.Post MJ, Yiannoutsos C, Simpson D, Booss J, Clifford DB, Cohen B, McArthur JC, Hall

27

CD: Progressive multifocal leukoencephalopathy in AIDS: Are there any MR findings useful to patient management and predictive of patient sur- vival? AIDS Clinical Trails Group, 243 Team. AJNR Am J Neuroradiol 20:1896–1906, 1999.

55. Rosenow JM, Hirschfeld A: Utility of brain biopsy in patients with acquired

immunodeficiency syndrome before and after the introduction of highly active antiretroviral therapy. Neurosurgery 61:130–141, 2007.

56.Seydoux C, Francioli P: Bacterial brain abscess: factors influencing mortality and sequelae. Clin Infect Dis. 15:394-401 1992

57.Stephanov S: Surgical treatment of brain abscess. Neurosurgery. 22:724-730 1988

58.Schroeder PC, Post MJ, Oschatz E, Stadler A, Bruce-Gregorios J, Thurner MM: Analysis of the utility of diffusion-weighted MRI and apparent diffusion coefficient values in distinguishing central nervous system toxoplasmosis from lymphoma. Neuroradiology 48:715–720, 2006.

59.Shitrit D, Lev N, Bar-Gil-Shitrit A, Kramer MR: Progressive multifocal

leukoencephalopathy in transplant recipients. Transpl Int 17:658–665, 2005.

60.Silverberg AL, DiNubile MJ: Subdural empyema and cranial epidural abscess. Med Clin North Am 69:361–374, 1985.

61.Singhi P, Dayal D, Khandelwal N: One week versus four weeks of albendazole therapy for neurocysticercosis in children: A randomized, placebo-con- trolled double blind trial. Pediatr Infect Dis J 22:268–272, 2003.

62.Smith HP, Hendrick EB: Subdural empyema and epidural abscess in children. J Neurosurg 58:392–397, 1983.

63.Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, Kennedy PG: Viral encephalitis: A review of diagnostic methods and guidelines for management. Eur J Neurol 12:331–343, 2005.

64.Tunkel A, Scheld M. Brain abscess. Youmans Neurological Surgery. Vol. 1. Sixth Ed. H. R.Winn. // 2001. – p. 588-599

65.Tunkel AR, Kaye D: Neurologic complications of infective endocarditis. Neurol Clin. 11:419-440 1993

66.Tunkel AR, Pradhan SK: Central nervous system infections in injection drug users. Infect Dis Clin North Am. 16:589-605 2002

67.Tunkel AR, Scheld WM. Pathogenesis and pathophysiology of bacterial infections. In: Scheld WM, Whitley RJ, Durack, DT, eds. Infections of the Central Nervous System, 2nd ed. Philadelphia: Lippincott-Raven; 1997;297-312

68.Tseng JH, Steng MY: Brain abscess in 142 patients: factors influencing outcome and mortality. Surg Neurol. 65:557-562 2006

69.Walsh TJ, Anaissie EJ, Denning DW, et al.: Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 46:327-360 2008

70.Wasay M, Kheleani BA, Moolani MK, Zaheer J, Pui M, Hasan S, Muzaffar S, Bakshi R, Sarawari AR: Brain CT and MRI findings in 100 consecutive patients with intracranial tuberculoma. J Neuroimaging 13:240–247, 2003.

71.Wasay M, Moolani MK, Zaheer J, Kheleani BA, Smego RA, Sarwari RA: Prognostic indicators in patients with intracranial tuberculoma: A review of 102 cases. J Pak Med Assoc 54:83–87, 2004.

72.Weingarten K, Zimmerman RD, Becker RD, Heier LA, Haimes AB, Deck MD: Subdural and epidural empyemas: MR imaging. AJR Am J Roentgenol 152:615–621, 1989.

73.Whitley RJ: Herpes simplex encephalitis: adolescents and adults. Antiviral Res 71:141–148, 2006.

28